Galen Growth Asia, the leading exclusive HealthTech research, analytics and advisory firm in Asia Pac (Asia) s...Read more
Xynomic Pharmaceuticals Holdings, Inc., a clinical stage US-China oncology drug development company, has annou...Read more
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
Stem cells gaining importance
Stem cell research stands as a high-priority field in the Asia-Pacific (APAC) and investment in these facilities are growing in order to increase competitiveness in the free market so that clinical applications can be continually discovered. Stringent regulations in Western Europe and the USA in stem cell therapy and regenerative medicine have driven the APAC to grow at the highest rate in this industry. Stem cell therapy is a hot topic in the field of medicine and is growing at a fast pace, BioSpectrum takes a look at how this exciting field is faring in the APAC region.